Actively Recruiting
KOrean Borderline Ovarian Tumor (KOBOT) Registry
Led by Kangbuk Samsung Hospital · Updated on 2019-04-03
3000
Participants Needed
4
Research Sites
2400 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to collect data on Korean patients with borderline ovarian tumors.
CONDITIONS
Official Title
KOrean Borderline Ovarian Tumor (KOBOT) Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with borderline ovarian tumors diagnosed, treated, and followed between November 1994 and February 2015 at Korean institutions
- Patients undergoing gynecologic surgery for borderline ovarian tumors at Korean institutions since March 2015
You will not qualify if you...
- Patients who did not receive primary treatment or follow-up for at least 6 months at each institution
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Samsung Changwon Hospital
Changwon, South Korea
Actively Recruiting
2
Kangbuk Samsung Hospital
Seoul, South Korea, 03181
Actively Recruiting
3
CHA Gangnam Medical Center
Seoul, South Korea, 06135
Actively Recruiting
4
Samsung Medical Center
Seoul, South Korea, 06351
Actively Recruiting
Research Team
T
Taejong Song, MD,PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here